...
hql-img

Tekla Life Sciences Investors, Common Stock

HQL

NYQ

$14.19

+$0.03

(0.21%)

1D
Industry: Capital Markets Sector: Financials

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$391.66M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
4.6579
Volume info-icon
This is the total number of shares traded during the most recent trading day.
80.64K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
14.12%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.70
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$11.4 L
$15.14 H
$14.19

About Tekla Life Sciences Investors, Common Stock

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. more

Industry: Capital MarketsSector: Financials

Returns

Time FrameHQLSectorS&P500
1-Week Return-0.28%-1.11%-0.77%
1-Month Return-6.95%-0.38%0.71%
3-Month Return-5.4%12.24%8.81%
6-Month Return2.9%21.66%12.32%
1-Year Return13.66%36.73%30.57%
3-Year Return-25.32%28.66%29.21%
5-Year Return-17.93%64.41%91.95%
10-Year Return-45.78%206.15%196.04%

Financials

Sep '19Sep '20Sep '21Sep '22Sep '235YR TREND
Total Revenue(69.34M)124.08M65.69M(103.25M)23.52M[{"date":"2019-09-30","value":-55.88,"profit":false},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":52.94,"profit":true},{"date":"2022-09-30","value":-83.21,"profit":false},{"date":"2023-09-30","value":18.96,"profit":true}]
Cost of Revenue4.48M4.78M5.60M5.55M5.24M[{"date":"2019-09-30","value":80.01,"profit":true},{"date":"2020-09-30","value":85.32,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":99.04,"profit":true},{"date":"2023-09-30","value":93.6,"profit":true}]
Gross Profit(69.34M)124.08M65.69M(103.25M)23.52M[{"date":"2019-09-30","value":-55.88,"profit":false},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":52.94,"profit":true},{"date":"2022-09-30","value":-83.21,"profit":false},{"date":"2023-09-30","value":18.96,"profit":true}]
Gross Margin100.00%100.00%100.00%100.00%100.00%[{"date":"2019-09-30","value":100,"profit":true},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Operating Expenses1.14M1.03M1.16M1.35M1.17M[{"date":"2019-09-30","value":84.02,"profit":true},{"date":"2020-09-30","value":76.14,"profit":true},{"date":"2021-09-30","value":85.59,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":86.6,"profit":true}]
Operating Income(70.48M)123.05M64.53M(104.60M)22.35M[{"date":"2019-09-30","value":-57.28,"profit":false},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":52.44,"profit":true},{"date":"2022-09-30","value":-85.01,"profit":false},{"date":"2023-09-30","value":18.16,"profit":true}]
Total Non-Operating Income/Expense(67.38M)153.62K-52.51K202.75K[{"date":"2019-09-30","value":-33234.96,"profit":false},{"date":"2020-09-30","value":75.77,"profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":25.9,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Pre-Tax Income(70.48M)123.05M64.53M(104.60M)22.35M[{"date":"2019-09-30","value":-57.28,"profit":false},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":52.44,"profit":true},{"date":"2022-09-30","value":-85.01,"profit":false},{"date":"2023-09-30","value":18.16,"profit":true}]
Income Taxes(2.88M)(2.13M)(4.15M)(2.99M)22.35M[{"date":"2019-09-30","value":-12.9,"profit":false},{"date":"2020-09-30","value":-9.51,"profit":false},{"date":"2021-09-30","value":-18.55,"profit":false},{"date":"2022-09-30","value":-13.37,"profit":false},{"date":"2023-09-30","value":100,"profit":true}]
Income After Taxes(67.59M)125.18M-(101.62M)(1.70K)[{"date":"2019-09-30","value":-54,"profit":false},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":-81.18,"profit":false},{"date":"2023-09-30","value":"-","profit":true}]
Income From Continuous Operations(70.48M)123.05M64.53M(104.60M)22.35M[{"date":"2019-09-30","value":-57.28,"profit":false},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":52.44,"profit":true},{"date":"2022-09-30","value":-85.01,"profit":false},{"date":"2023-09-30","value":18.16,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Net Income(70.48M)123.05M64.53M(104.60M)22.35M[{"date":"2019-09-30","value":-57.28,"profit":false},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":52.44,"profit":true},{"date":"2022-09-30","value":-85.01,"profit":false},{"date":"2023-09-30","value":18.16,"profit":true}]
EPS (Diluted)(4.59)7.713.94(4.11)-[{"date":"2019-09-30","value":-59.51,"profit":false},{"date":"2020-09-30","value":100,"profit":true},{"date":"2021-09-30","value":51.1,"profit":true},{"date":"2022-09-30","value":-53.33,"profit":false},{"date":"2023-09-30","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HQL
Cash Ratio 15.73
Current Ratio 0.20
Quick Ratio 15.92

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HQL
ROA (LTM) -0.32%
ROE (LTM) 1.28%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HQL
Debt Ratio Lower is generally better. Negative is bad. 0.00
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 1.00

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HQL
Trailing PE 4.66
Forward PE NM
P/S (TTM) 111.49
P/B 0.84
EV/R 4.47
EV/Ebitda NM
PEG NM

FAQs

What is Tekla Life Sciences Investors share price today?

Tekla Life Sciences Investors (HQL) share price today is $14.19

Can Indians buy Tekla Life Sciences Investors shares?

Yes, Indians can buy shares of Tekla Life Sciences Investors (HQL) on Vested. To buy Tekla Life Sciences Investors from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HQL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Tekla Life Sciences Investors be purchased?

Yes, you can purchase fractional shares of Tekla Life Sciences Investors (HQL) via the Vested app. You can start investing in Tekla Life Sciences Investors (HQL) with a minimum investment of $1.

How to invest in Tekla Life Sciences Investors shares from India?

You can invest in shares of Tekla Life Sciences Investors (HQL) via Vested in three simple steps:

  • Click on Sign Up or Invest in HQL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Tekla Life Sciences Investors shares
What is Tekla Life Sciences Investors 52-week high and low stock price?

The 52-week high price of Tekla Life Sciences Investors (HQL) is $15.14. The 52-week low price of Tekla Life Sciences Investors (HQL) is $11.4.

What is Tekla Life Sciences Investors price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Tekla Life Sciences Investors (HQL) is 4.6579

What is Tekla Life Sciences Investors price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Tekla Life Sciences Investors (HQL) is 0.84

What is Tekla Life Sciences Investors dividend yield?

The dividend yield of Tekla Life Sciences Investors (HQL) is 14.12%

What is the Market Cap of Tekla Life Sciences Investors?

The market capitalization of Tekla Life Sciences Investors (HQL) is $391.66M

What is Tekla Life Sciences Investors’s stock symbol?

The stock symbol (or ticker) of Tekla Life Sciences Investors is HQL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top